American Journal of Preventive Cardiology
Scope & Guideline
Innovating Strategies to Combat Cardiovascular Disease.
Introduction
Aims and Scopes
- Cardiovascular Risk Assessment and Management:
The journal emphasizes the importance of comprehensive cardiovascular risk assessment, including the use of traditional and novel biomarkers, imaging techniques, and clinical guidelines to optimize prevention strategies for cardiovascular diseases. - Innovative Therapeutics and Interventions:
It focuses on the exploration of innovative therapeutic approaches, such as lipid-lowering therapies, lifestyle modifications, and pharmacological interventions aimed at reducing cardiovascular risk and improving patient outcomes. - Health Disparities and Social Determinants of Health:
Research addressing health disparities in cardiovascular health across different populations, including the impact of socioeconomic status, race, and gender on cardiovascular disease prevalence and outcomes is a core area of focus. - Preventive Strategies and Public Health Initiatives:
The journal highlights effective public health interventions and community-based strategies that promote cardiovascular health, including educational initiatives and policy recommendations aimed at reducing the burden of cardiovascular diseases. - Epidemiological Studies and Clinical Trials:
It publishes findings from epidemiological studies and clinical trials that provide insights into the prevalence, risk factors, and outcomes of cardiovascular diseases, fostering evidence-based practices in preventive cardiology.
Trending and Emerging
- Integrative Approaches to Cardiovascular Health:
There is a growing trend towards integrating lifestyle modifications, mental health considerations, and social determinants of health into cardiovascular care, recognizing the multifaceted nature of cardiovascular disease prevention. - Emerging Biomarkers and Genetic Testing:
The exploration of novel biomarkers, including lipoprotein(a) and genetic risk factors, is gaining traction, reflecting a shift towards personalized medicine and precision approaches in cardiovascular risk assessment. - Impact of COVID-19 on Cardiovascular Health:
Research examining the long-term effects of the COVID-19 pandemic on cardiovascular health, including changes in risk factor management and healthcare access, is increasingly prevalent as the healthcare landscape evolves. - Telehealth and Remote Monitoring:
The rise of telehealth services and remote monitoring technologies for cardiovascular risk management has emerged as a significant theme, driven by the necessity for innovative care delivery models during the pandemic. - Focus on Women's Cardiovascular Health:
There is an increasing emphasis on research dedicated to understanding and addressing cardiovascular health disparities among women, including the unique risk factors and outcomes that affect this population.
Declining or Waning
- Traditional Lipid Management Approaches:
While lipid management remains crucial, there is a noted decline in publications focusing solely on traditional lipid measures (e.g., total cholesterol) without considering emerging biomarkers and personalized approaches. - Generalized Interventions without Tailoring:
Research that addresses generalized preventive interventions without consideration for individual patient characteristics or risk profiles appears to be diminishing, as the focus shifts toward more personalized and targeted strategies. - Single-Disease Focus:
There is a waning emphasis on studies that concentrate exclusively on single cardiovascular diseases, such as coronary artery disease, as the journal increasingly promotes a more holistic view of cardiovascular health that considers multi-morbidity. - Conventional Guidelines without Novel Insights:
The journal is seeing fewer articles that simply reiterate existing guidelines without contributing new insights or evidence, as there is a greater demand for innovative and evidence-based recommendations.
Similar Journals
International Journal of Cardiology
Connecting Researchers and Clinicians to Shape Heart HealthThe International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.
Aktuelle Kardiologie
Empowering healthcare professionals with cutting-edge findings.Aktuelle Kardiologie is a premier journal in the field of cardiology, published by GEORG THIEME VERLAG KG. With its ISSN 2193-5203 and E-ISSN 2193-5211, it serves as an essential resource for cardiologists, researchers, and healthcare professionals who seek to stay abreast of the latest developments in cardiovascular medicine. Although currently not open access, the journal provides comprehensive insights through its rigorous peer-review process, ensuring high-quality content for its readers. Located in Stuttgart, Germany, the journal’s objectives include fostering the exchange of innovative research, clinical findings, and expert opinions that can significantly enhance patient care and inspire further studies in cardiovascular health. In an era where cardiovascular diseases are a leading public health concern, Aktuelle Kardiologie remains a vital platform for disseminating critical knowledge and advancing the field.
Korean Circulation Journal
Bridging Research and Practice in Cardiology.Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.
Current Cardiovascular Risk Reports
Advancing cardiovascular knowledge for a healthier tomorrow.Current Cardiovascular Risk Reports, published by SPRINGER, is an authoritative journal that serves the dynamic field of cardiovascular research. With an ISSN of 1932-9520 and E-ISSN 1932-9563, this journal provides a platform for innovative studies that address emerging topics in cardiovascular risk assessment and prevention strategies. Since its inception in 2007, it has consistently provided researchers and healthcare professionals with timely insights and comprehensive analyses in the cardiovascular domain. Holding a respectable Q3 ranking in the pharmacology categories according to the 2023 metrics, it is positioned among the key publications in its field. The journal is dedicated to improving cardiovascular health outcomes by publishing high-quality research, reviews, and clinical studies that are pivotal for understanding risk factors and therapeutic advances. Although not an open-access publication, Current Cardiovascular Risk Reports plays a crucial role in disseminating knowledge to its audience and fostering collaboration across various disciplines in medicine, pharmacology, and public health.
HEART
Shaping the Future of Cardiology with Cutting-Edge ResearchHEART is a leading peer-reviewed journal published by the BMJ Publishing Group, specializing in the field of Cardiology and Cardiovascular Medicine. Established in 1942, the journal has evolved as a premier platform for disseminating high-quality research, innovative practices, and clinical advancements within the cardiovascular domain. With an impressive impact factor and ranked in the Q1 category in 2023, it positions itself among the top-tier journals in its field, boasting a Scopus rank of #37 out of 387 in this highly competitive area, representing the top 10th percentile nationally. The journal supports both traditional and open access options, thereby enhancing the global visibility and reach of its published work. Researchers, professionals, and students alike will find HEART to be an invaluable resource, offering the latest insights and developments that drive the field forward and improve patient care worldwide.
Clinica e Investigacion en Arteriosclerosis
Exploring innovative solutions in arterial disease management.Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.
International Heart Journal
Empowering Healthcare Professionals with Cutting-edge InsightsInternational Heart Journal, published by INT HEART JOURNAL ASSOC, serves as a pivotal platform for research and discourse in the fields of cardiology and cardiovascular medicine. With its ISSN 1349-2365 and E-ISSN 1349-3299, this esteemed journal is based in Japan and is located at the University of Tokyo, Graduate School of Medicine, Department of Cardiovascular Medicine. Since its inception in 2005, International Heart Journal has blossomed into a respected publication with an impact factor that signifies its growing relevance, ranking in the Q3 category of both cardiology and miscellaneous medicine as of 2023. This journal not only disseminates vital research findings but also fosters collaboration among researchers and healthcare professionals. Notable for its Open Access options, it ensures the availability of its content to a broader audience, thereby enhancing knowledge transfer and innovation in cardiovascular care. With an ongoing commitment to improve clinical practice and patient outcomes, the journal continues to be an essential resource for those dedicated to advancing the understanding of heart health and disease.
Cardiology Research
Pioneering innovative research in cardiology and heart health.Cardiology Research is a prominent open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine, published by ELMER PRESS INC. Renowned for its rigorous peer-review process, the journal provides a platform for cutting-edge research and innovative clinical practices in cardiology. With an ISSN of 1923-2829 and an E-ISSN of 1923-2837, it has established an impactful presence in the academic community, achieving a 2023 Scopus quartile ranking of Q3 in its category, positioning it in the 41st percentile. The journal's scope encompasses various aspects of cardiology research, including but not limited to epidemiology, diagnostics, therapeutics, and cardiovascular interventions. Although it operates without open access in certain contexts, it provides flexible access options for readers, ensuring that its valuable insights are widely disseminated. Cardiology Research is an essential resource for researchers, healthcare professionals, and students who aspire to stay at the forefront of cardiovascular science, contributing significantly to the global discourse on heart health.
Cardiology in Review
Bridging research and practice in cardiology.Cardiology in Review, published by Lippincott Williams & Wilkins, is a prominent journal focused on advancing the field of cardiology and cardiovascular medicine. With a history of publication spanning from 1995 to 2024, the journal serves as an essential resource for researchers, healthcare professionals, and students alike, offering in-depth reviews and analyses on the latest developments, clinical practices, and research findings in cardiology. Despite being a traditional print journal, it maintains a commendable Q2 ranking in both cardiology and miscellaneous medicine categories as of 2023, reflecting its influence and rigor in the academic community, with a Scopus rank of #132 out of 387 in its field, placing it in the 66th percentile. The journal aims to bridge the gap between clinical practice and emerging research, promoting a deeper understanding and integration of innovative strategies in cardiovascular care. With its commitment to high-quality scholarship, Cardiology in Review remains a vital conduit for knowledge and dialogue within the evolving landscape of cardiovascular health.
CIRCULATION JOURNAL
Advancing Cardiovascular Knowledge, One Study at a Time.CIRCULATION JOURNAL, published by the Japanese Circulation Society, stands as a premier platform for cutting-edge research in the fields of Cardiology and Cardiovascular Medicine. With an impressive impact factor placing it in the Q1 quartile for both cardiology and general medicine, this journal is essential for researchers and practitioners seeking to stay at the forefront of cardiovascular science. The journal's accessible open access options ensure that groundbreaking studies are widely disseminated, reflecting its commitment to advancing medical knowledge and improving patient care. Since its inception in 1996, CIRCULATION JOURNAL has fostered a global dialogue on vital cardiovascular issues, making it a vital resource for academics, healthcare professionals, and students alike. With its base in Tokyo, Japan, the journal not only highlights regional advancements but also contributes significantly to the global medical community.